Japan News
-
Edison Pharma, DSP enter $4 bn metablosim drug deal
Japan | News | By BioSpectrum Bureau | 0 Comment | 04 Feb, 2014
Singapore: US-based Edison Pharmaceuticals has entered into a strategic alliance valued up to $4.295 billion with Japan'...Read more
-
Gilead files NDA for Hep C drug in Japan
Japan | News | By BioSpectrum Bureau | 0 Comment | 30 Jun, 2014
Singapore: US-based Gilead Sciences has submitted a New Drug Application (NDA) to Japan's Pharmaceutical and Medical Dev...Read more
-
AnGes, Mitsubishi Tanabe sign MoU to market Collategene
Japan | News | By BioSpectrum Bureau | 0 Comment | 29 Oct, 2012
Singapore: AnGes MG entered into a definitive agreement with Mitsubishi Tanabe Pharma for the exclusive marketing right...Read more
-
What the future holds for the APAC CRO market?
Japan | Analysis | By BioSpectrum Bureau | 4 Comment | 18 Sep, 2013
The fifth edition of the annual BioSpectrum Asia Pacific clinical research organization (CRO) Survey, which is conduct...Read more
-
Japan scientists pioneer new stem cell technology
Japan | News | By BioSpectrum Bureau | 0 Comment | 24 Jul, 2012
Singapore: A research team at the tissue regeneration materials unit, National Institute for Materials Science (NIMS), s...Read more
-
Astellas gets FDA nod for kidney transplant drug
Japan | News | By BioSpectrum Bureau | 0 Comment | 22 Jul, 2013
Singapore: Japan-based Astellas Pharma has received US FDA approval for Astagraf XL (tacrolimus extended-release capsule...Read more
-
Global collaborations is the way forward for drug discovery
Japan | Analysis | By BioSpectrum Bureau | 1 Comment | 19 Dec, 2012
Over the last few decades India has reiterated its capabilities in providing dependable and cost effective chemistry ser...Read more
-
Pfizer, Mylan enter generics deal in Japan
Japan | News | By BioSpectrum Bureau | 0 Comment | 23 Aug, 2012
Singapore: Pfizer and Mylan have signed a definitive agreement to establish an exclusive long-term strategic collaborati...Read more
-
Takara Bio enters deal with Invivoscribe
Japan | News | By BioSpectrum Bureau | 0 Comment | 06 Dec, 2012
Singapore: Japanese firm Takara Bio has entered into an agreement with Invivoscribe Technologies to grant the latter lic...Read more
-
NuVasive spine surgery implant approved in Japan
Japan | News | By BioSpectrum Bureau | 0 Comment | 19 Dec, 2012
Singapore: NuVasive, a medical device company focused on developing minimally disruptive surgical products and procedur...Read more
-
Mitsubishi to acquire Medicago at $1.16 per share
Japan | News | By BioSpectrum Bureau | 0 Comment | 17 Jul, 2013
Singapore: Medicago, a biopharmaceutical company focused on developing highly effective and competitive vaccines based o...Read more
-
Kinetic launches portable negative pressure therapy
Japan | News | By BioSpectrum Bureau | 0 Comment | 10 Apr, 2013
Singapore: US-based Kinetic Concepts (KCI) has launched ActiVAC Therapy System for in-patient use in Japan, which is a l...Read more
-
Terumo and Biosensors to sell Nabori DES system
Japan | News | By BioSpectrum Bureau | 0 Comment | 24 Apr, 2012
Singapore: Terumo and Biosensors International announced an extension of their existing licensing agreements, under w...Read more
-
Otsuka, Lundbeck files NDA for schizophrenia drug
Japan | News | By BioSpectrum Bureau | 0 Comment | 15 Jul, 2014
Singapore: Japanese firm Otsuka Pharmaceutical and global firm H Lundbeck have submitted a New Drug Application (NDA) to...Read more
-
HealthPatch MD receives Japanese nod
Japan | News | By BioSpectrum Bureau | 0 Comment | 19 Feb, 2015
Singapore: Vital Connect recently announced that its wearable device HealthPatch MD has received approval for sale in th...Read more
-
Amgen-Cytokinetics collaboration to include Japan
Japan | News | By BioSpectrum Bureau | 0 Comment | 17 Jun, 2013
Singapore: USA-based Amgen, the world's largest independent biotech company, has expanded its strategic collaboration wi...Read more
-
Taiho seeks Japanese nod for oral cancer agent
Japan | News | By BioSpectrum Bureau | 0 Comment | 28 Feb, 2013
Singapore: Taiho Pharmaceutical submitted an application for approval of the manufacture and marketing of the novel oral...Read more
-
Japan | News | By BioSpectrum Bureau | 0 Comment | 24 Apr, 2012
Singapore: Eisai announced that its U.S. subsidiary has received approval from the U.S. Food and Drug Administration (F...Read more
